Sleep apnea is a potentially serious sleep disorder that occurs when a person’s breathing is interrupted during sleep. People with untreated sleep apnea stop breathing repeatedly during their sleep, sometimes hundreds of times during the night. There are two types of sleep apnea: obstructive and central. Obstructive sleep apnea (OSA) is the more common of the two. Obstructive sleep apnea is characterized by repetitive episodes of complete or partial upper airway blockage during sleep in central sleep apnea (CSA), the airway is not blocked but the brain fails to signal the muscles to breathe due to instability in the respiratory control center.
The Global Sleep Apnea Devices Market was valued at $ 5.1 bn in 2018 and is forecasted to grow at a 7.1% CAGR between 2018 and 2026, resulting in 2026 global sales of $ 8.83 bn. The market is driven by the owing presentation of technological developments and rising usage of sleep apnea. However, the absence of patient compliance is hindering the market growth. Moreover, the growing focus on Mhealth and telemedicine is providing ample opportunities for the market.
Sleep Apnea Devices depending on end-user, sleep laboratories & hospitals segment is expected to account for the largest share of the Sleep Apnea Devices market due to the portfolio of devices used in sleep laboratories and hospitals are limited mainly to diagnostic devices, example tabletop pulse oximeters, actigraphy systems, and clinical PSG devices.
The Global Sleep Apnea Devices Market is segmented on the basis of type, alternate therapies, epidemiological assessment, end-user, and region
Based on the Type: Diagnostic devices, and therapeutic devices
Based on the Epidemiological Assessment: Prescription pattern assessment, epidemiological assessment, and adherence assessment
Based on the Alternate Therapies: Positional Therapy, Oral Pressure Therapy, Hypoglossal Nerve Stimulation, and Expiratory Positive Airway Pressure
Based on the End User: Home Care Settings/Individuals and Sleep Laboratories & Hospitals
Based on the Region: North America, Asia-Pacific, Europe, and LAMEA. Among that Asia-Pacific held the largest share of the market due to initiatives taken by the government & other private organizations to increase responsiveness about sleep disorders, the large undiagnosed pool in countries like India, strategic agreements of global market leaders with regional players and rising prevalence of sleep apnea disorders in this region
The key players of the Global Sleep Apnea Devices Market include Braebon Medical Corporation, BMC Medical Co., Ltd, Drive Devilbiss Healthcare, Löwenstein Medical, Oventus Medical, Fisher & Paykel Healthcare, ResMed, Curative Medical Inc, ImThera Medical Inc, Invacare Corporation and Itamar Medical Ltd
The report covers in-depth analysis of Global Sleep Apnea Devices Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by Type (Diagnostic devices, and therapeutic devices). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in Global Sleep Apnea Devices Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.